Haichuan Zhu

8PUBLICATIONS
17CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCryptographyHaematological tumoursEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 14, 2026
Combining Small-Molecular Compounds With CAR T-Cell Therapy: Novel Strategies for Enhanced Cancer Immunotherapy.

Rangzi Yi, Zijian Zhang, Yang Yang

|Feb 16, 2025
5-hydroxymethylcytosine features of portal venous blood predict metachronous liver metastases of colorectal cancer and reveal phosphodiesterase 4 as a therapeutic target.

Nuo Xu, Zhaoya Gao, Deyan Wu

|Jan 13, 2025
ETV7 limits the antiviral and antitumor efficacy of CD8+ T cells by diverting their fate toward exhaustion.

Jie Cheng, Yifeng Xiao, Ting Peng

|Jan 06, 2025
The epitranscriptional factor PCIF1 orchestrates CD8+ T cell ferroptosis and activation to control antitumor immunity.

Bolin Xiang, Meiling Zhang, Kai Li

|Apr 28, 2023
T-ALL Cells as Tool Cells for CAR T Therapy.

Anqi Ren, Yuan Zhao, Haichuan Zhu

|Jan 21, 2023
CAR T-Cell Immunotherapy Treating T-ALL: Challenges and Opportunities.

Anqi Ren, Xiqin Tong, Na Xu

Pageof 2

Frequent Collaborators

1 joint publications

Yue Xue

1 joint publications

Hao Tian

1 joint publications

Hui Quan

1 joint publications

Sirui Liu